Clinical trial
ZD6474 to Treat Advanced Brain Cancer in Patients
NCT00272350 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00272350 |
|---|---|
| Title | ZD6474 to Treat Advanced Brain Cancer in Patients |
| Official title | A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent High-Grade Gliomas, Progressive Low-Grade Gliomas, Malignant Gliomas |
| Intervention type | Drug |
| Interventions | Steroids, ZD6474 |
| Enrollment | 83 |
| Start date | Dec 29, 2005 |
| Primary completion | Feb 27, 2014 |
| Completion | Feb 27, 2014 |
| First posted | Jan 5, 2006 |
| Last update posted | Dec 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: